arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Cardiff Lexington Corp

CDIX
Price unavailable
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
76 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
75
Health
Good
Moderately Bullish
auto_awesome

Analytical Summary

Cardiff Lexington Corp demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap
Dividend Yield
Revenue Growth -23.8%
Op. Margin -23.0%
ROIC -10.4%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

76-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.22M
↓ -23.8%
Net Income Profit after all expenses
$-3.09M
↓ -585.9%
Operating Margin Operating profit as % of sales
-23.0%
↑ +8.4% 55th
FCF / Share Free cash flow per share
$-0.00
↑ +98.6%
Long-Term Debt Long-term obligations
$18.56M
↑ +23.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
100
Financial Health
98

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 21 years · 76 quarters